Thermo Fisher Scientific stock gains on strong second-quarter results

Thermo Fisher Scientific Inc. (ISIN US8835561023) stock closed at USD 648.43 on September 16, 2026, up 1.1 percent from the prior close of USD 641.39. The move followed a second-quarter print that showed USD 11.99 billion in revenue and adjusted EPS of USD 6.03, both dated July 23, 2026.

Second-quarter growth held up

According to Yahoo Finance, Thermo Fisher posted second-quarter revenue of USD 11.99 billion, up 10.5 percent year over year, with 5 percent organic growth. The same report said adjusted EPS rose 12.5 percent to USD 6.03 and came in USD 0.32 above the Street estimate.

That combination matters for investors because the company also raised full-year guidance on both lines in the same second-quarter update dated July 23, 2026, while the report said organic growth was 2 percentage points ahead of the guidance set one quarter earlier.

Analysts disagree on valuation

According to Yahoo Finance, CLSA started coverage on September 3, 2026 with an Outperform rating and a USD 748 target, while UBS lifted its target to USD 730 from USD 540 on September 9, 2026 and Bernstein stayed at Hold with USD 575. The same article put the Street average near USD 645, close to the share price level it cited.

That spread shows the debate is now about valuation, not the last quarter. UBS tied its more positive call to 5 percent to 6 percent organic growth, 50 to 70 basis points of margin expansion and double-digit EPS growth in its model.

Stock near its high

Thermo Fisher Scientific shares were last quoted at USD 648.43 on September 16, 2026, with a 52-week range of USD 435.27 to USD 653.40 and a market capitalization of USD 239.76 billion, according to Morningstar. The stock was sitting just below its 52-week high of USD 653.40 after a session that also showed a prior close of USD 641.39 and volume of 1,718 shares.

More news and analyses on Thermo Fisher Scientific stock